Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, View ORCID ProfileCharles Y. Chiu
doi: https://doi.org/10.1101/2021.08.19.21262139
Venice Servellita
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Mary-Kate Morris
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
Alicia Sotomayor-Gonzalez
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Amelia S. Gliwa
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Erika Torres
4Color Genomics, Inc., San Francisco, California, USA
Noah Brazer
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Alicia Zhou
4Color Genomics, Inc., San Francisco, California, USA
Katherine T. Hernandez
5San Francisco Department of Public Health, San Francisco, California, USA
Madeline Sankaran
5San Francisco Department of Public Health, San Francisco, California, USA
Baolin Wang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Daniel Wong
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Candace Wang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Yueyuan Zhang
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Kevin R Reyes
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Dustin Glasner
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Xianding Deng
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Jessica Streithorst
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Steve Miller
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
Edwin Frias
6Abbott Laboratories, Abbott Park, Illinois, USA
John Hackett Jr.
6Abbott Laboratories, Abbott Park, Illinois, USA
Carl Hanson
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
Debra Wadford
3Viral and Rickettsial Disease Laboratory, California Department of Public Health
Susan Philip
5San Francisco Department of Public Health, San Francisco, California, USA
Scott Topper
4Color Genomics, Inc., San Francisco, California, USA
Darpun Sachdev
5San Francisco Department of Public Health, San Francisco, California, USA
Charles Y. Chiu
1Department of Laboratory Medicine, University of California San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
7Department of Medicine, University of California San Francisco, California, USA
8Innovative Genomics Institute, University of California Berkeley, Berkeley, California, USA
Data Availability
Data Availability Assembled SARS-CoV-2 genomes in this study were uploaded to GISAID (accession numbers in Supplementary Table S2) and can be visualized in NextStrain. Viral genomes were also submitted to the National Center for Biotechnology Information (NCBI) GenBank database (accession numbers pending). Raw sequence data were submitted to the Sequence Read Archive (SRA) database. (BioProject accession number PRJNA722044 and umbrella BioProject accession number PRJNA171119). Code Availability FASTA files and scripting code for data analyses are available in a Zenodo data repository (https://doi.org/10.5281/zenodo.5207242).
Posted August 25, 2021.
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
medRxiv 2021.08.19.21262139; doi: https://doi.org/10.1101/2021.08.19.21262139
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
Venice Servellita, Mary-Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, Alicia Zhou, Katherine T. Hernandez, Madeline Sankaran, Baolin Wang, Daniel Wong, Candace Wang, Yueyuan Zhang, Kevin R Reyes, Dustin Glasner, Xianding Deng, Jessica Streithorst, Steve Miller, Edwin Frias, John Hackett Jr., Carl Hanson, Debra Wadford, Susan Philip, Scott Topper, Darpun Sachdev, Charles Y. Chiu
medRxiv 2021.08.19.21262139; doi: https://doi.org/10.1101/2021.08.19.21262139
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2885)
- Dermatology (247)
- Emergency Medicine (433)
- Epidemiology (12626)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4487)
- Geriatric Medicine (410)
- Health Economics (717)
- Health Informatics (2870)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (912)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4254)
- Nursing (228)
- Nutrition (622)
- Oncology (2229)
- Ophthalmology (635)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6834)
- Radiology and Imaging (1504)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)